DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Blackwell KL, Burstein HJ, Storniolo AM et al.
Overall survival benefit with lapatinib in combination with trastuzumab for
patients with human epidermal growth factor receptor 2-positive metastatic
breast cancer: final results from the EGF104900 Study.
J Clin Oncol 2012;
30: 2585-2592
Access:
We do not assume any responsibility for the contents of the web pages of other providers.